{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:55:00Z","timestamp":1768568100300,"version":"3.49.0"},"posted":{"date-parts":[[2024,6,16]]},"group-title":"Neurology","reference-count":66,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Inclusion body myositis (IBM) is the most prevalent muscle disease in adults for which no current treatment exists. The pathogenesis of IBM remains poorly defined. Inflammation and mitochondrial dysfunction are the most common histopathological findings. In this study, we aimed to explore the interplay between inflammation and mitochondrial dysfunction in IBM patients, highlighting sex differences.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included 38 IBM patients and 22 age- and sex-matched controls without myopathy. Bulk RNA sequencing, Meso Scale Discovery ELISA, western blotting, histochemistry and immunohistochemistry were performed on frozen muscle samples from the study participants.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    We demonstrated activation of the NLRP3 inflammasome in IBM muscle samples, with the NLRP3 inflammasome pathway being the most upregulated. On muscle histopathology, there is increased NRLP3 immunoreactivity in both inflammatory cells and muscle fibers. Mitophagy is critical for removing damaged mitochondria and preventing the formation of a vicious cycle of mitochondrial dysfunction\u2014NLRP3 activation. In the IBM muscle samples, we showed altered mitophagy, most significantly in males, with elevated levels of p-S65-Ubiquitin, a mitophagy marker. Furthermore, p-S65-Ubiquitin aggregates accumulated in muscle fibers that were mostly type 2 and devoid of cytochrome-c-oxidase reactivity. Type 2 muscle fibers are known to be more prone to mitochondrial dysfunction.\n                    <jats:italic>NLRP3 RNA<\/jats:italic>\n                    levels correlated with p-S65-Ubiquitin levels in both sexes but with loss of in muscle strength only in males. Finally, we identified sex-specific molecular pathways in IBM, with females having activation of pathways that could offset some of the pathomechanisms of IBM.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>NLRP3 inflammasome is activated in IBM, along with altered mitophagy particularly in males, which is of potential therapeutic significance. These findings suggest sex-specific mechanisms in IBM that warrant further investigation.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2024.06.15.24308845","type":"posted-content","created":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T16:55:13Z","timestamp":1718556913000},"source":"Crossref","is-referenced-by-count":1,"title":["NLRP3 inflammasome activation and altered mitophagy are key pathways in inclusion body myositis"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-1236","authenticated-orcid":false,"given":"Elie","family":"Naddaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thi Kim Oanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens O.","family":"Watzlawik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanyao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3011-4378","authenticated-orcid":false,"given":"Xu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne C.","family":"Fiesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Mandrekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Kokesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian R.","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfdieter","family":"Springer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Trushina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024062101002341000_2024.06.15.24308845v1.1","first-page":"1586","article-title":"Sporadic Inclusion Body Myositis and Other Rimmed Vacuolar Myopathies","volume":"25","year":"2019","journal-title":"Continuum (Minneapolis, Minn)"},{"key":"2024062101002341000_2024.06.15.24308845v1.2","doi-asserted-by":"crossref","first-page":"1020113","DOI":"10.3389\/fneur.2022.1020113","article-title":"Inclusion body myositis: Update on the diagnostic and therapeutic landscape","volume":"13","year":"2022","journal-title":"Front Neurol"},{"key":"2024062101002341000_2024.06.15.24308845v1.3","doi-asserted-by":"crossref","unstructured":"Shelly S , Mielke MM , Mandrekar J , et al. Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study. Neurology 2021.","DOI":"10.1212\/WNL.0000000000012004"},{"key":"2024062101002341000_2024.06.15.24308845v1.4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab716"},{"key":"2024062101002341000_2024.06.15.24308845v1.5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410160207"},{"key":"2024062101002341000_2024.06.15.24308845v1.6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.10.2030"},{"key":"2024062101002341000_2024.06.15.24308845v1.7","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/brain\/awz207","article-title":"Highly differentiated cytotoxic T cells in inclusion body myositis","volume":"142","year":"2019","journal-title":"Brain"},{"key":"2024062101002341000_2024.06.15.24308845v1.8","doi-asserted-by":"publisher","DOI":"10.3233\/JND-160198"},{"key":"2024062101002341000_2024.06.15.24308845v1.9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/BOR.0000000000000958","article-title":"Exploring challenges in the management and treatment of inclusion body myositis","volume":"35","year":"2023","journal-title":"Current opinion in rheumatology"},{"key":"2024062101002341000_2024.06.15.24308845v1.10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ana.26412","article-title":"Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis","volume":"92","year":"2022","journal-title":"Ann Neurol"},{"key":"2024062101002341000_2024.06.15.24308845v1.11","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21386"},{"key":"2024062101002341000_2024.06.15.24308845v1.12","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1991.00530240033013"},{"key":"2024062101002341000_2024.06.15.24308845v1.13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbadis.2014.09.005","article-title":"Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy","volume":"1852","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"2024062101002341000_2024.06.15.24308845v1.14","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000277527.69388.fe"},{"key":"2024062101002341000_2024.06.15.24308845v1.15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0960-8966(02)00098-6","article-title":"Inclusion body myositis: morphological clues to correct diagnosis","volume":"12","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"2024062101002341000_2024.06.15.24308845v1.16","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199507000-00012"},{"key":"2024062101002341000_2024.06.15.24308845v1.17","first-page":"e12931","article-title":"Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing. Brain pathology (Zurich","volume":"31","year":"2021","journal-title":"Switzerland)"},{"key":"2024062101002341000_2024.06.15.24308845v1.18","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12149"},{"key":"2024062101002341000_2024.06.15.24308845v1.19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JPD-160989","article-title":"PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson\u2019s Disease Pathobiology?","volume":"7","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"2024062101002341000_2024.06.15.24308845v1.20","doi-asserted-by":"crossref","unstructured":"Chatzinikita E , Maridaki M , Palikaras K , Koutsilieris M , Philippou A . The Role of Mitophagy in Skeletal Muscle Damage and Regeneration. Cells 2023;12.","DOI":"10.3390\/cells12050716"},{"key":"2024062101002341000_2024.06.15.24308845v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2014.09.007"},{"key":"2024062101002341000_2024.06.15.24308845v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.12.029"},{"key":"2024062101002341000_2024.06.15.24308845v1.23","first-page":"e1193","article-title":"Identification of distinctive interferon gene signatures in different types of myositis","volume":"93","year":"2019","journal-title":"Neurology"},{"key":"2024062101002341000_2024.06.15.24308845v1.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-eular.2177"},{"key":"2024062101002341000_2024.06.15.24308845v1.25","doi-asserted-by":"crossref","unstructured":"Johari M , Vihola A , Palmio J , et al. Comprehensive transcriptomic analysis shows disturbed calcium homeostasis and deregulation of T lymphocyte apoptosis in inclusion body myositis. J Neurol 2022.","DOI":"10.1101\/2021.06.30.450477"},{"key":"2024062101002341000_2024.06.15.24308845v1.26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41927-020-00125-8","article-title":"MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies","volume":"4","year":"2020","journal-title":"BMC Rheumatology"},{"key":"2024062101002341000_2024.06.15.24308845v1.27","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acn3.51657","article-title":"Metabolome and transcriptome analysis on muscle of sporadic inclusion body myositis","volume":"9","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2024062101002341000_2024.06.15.24308845v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26304"},{"key":"2024062101002341000_2024.06.15.24308845v1.29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/ene.12627","article-title":"High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study","volume":"22","year":"2015","journal-title":"European journal of neurology"},{"key":"2024062101002341000_2024.06.15.24308845v1.30","doi-asserted-by":"crossref","unstructured":"Michelle EH , Pinal-Fernandez I , Casal-Dominguez M , et al. Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis. Neurology 2023.","DOI":"10.1212\/WNL.0000000000206777"},{"key":"2024062101002341000_2024.06.15.24308845v1.31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr217"},{"key":"2024062101002341000_2024.06.15.24308845v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.08.007"},{"key":"2024062101002341000_2024.06.15.24308845v1.33","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1093\/rheumatology\/keab754","article-title":"Inclusion body myositis: correlation of clinical outcomes with histopathology, electromyography and laboratory findings","volume":"61","year":"2022","journal-title":"Rheumatology (Oxford, England)"},{"key":"2024062101002341000_2024.06.15.24308845v1.34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/mus.27716","article-title":"Atypical presentations of inclusion body myositis: Clinical characteristics and long-term outcomes","volume":"66","year":"2022","journal-title":"Muscle Nerve"},{"key":"2024062101002341000_2024.06.15.24308845v1.35","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"2024062101002341000_2024.06.15.24308845v1.36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2024062101002341000_2024.06.15.24308845v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/ng1180"},{"key":"2024062101002341000_2024.06.15.24308845v1.38","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1080\/15548627.2020.1834712","article-title":"Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples","volume":"17","year":"2021","journal-title":"Autophagy"},{"key":"2024062101002341000_2024.06.15.24308845v1.39","doi-asserted-by":"crossref","unstructured":"Watzlawik JO , Fiesel FC , Fiorino G , et al. Basal activity of PINK1 and PRKN in cell models and rodent brain. Autophagy 2023:1\u201312.","DOI":"10.1080\/15548627.2023.2286414"},{"key":"2024062101002341000_2024.06.15.24308845v1.40","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201540514"},{"key":"2024062101002341000_2024.06.15.24308845v1.41","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1080\/15548627.2018.1461294","article-title":"Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease","volume":"14","year":"2018","journal-title":"Autophagy"},{"key":"2024062101002341000_2024.06.15.24308845v1.42","first-page":"100","article-title":"Tumor protein P63 Regulated 1 contributes to inflammation and cell proliferation of cystitis glandularis through regulating the NF-\u043aB\/cyclooxygenase-2\/prostaglandin E2 axis","volume":"22","year":"2022","journal-title":"Bosn J Basic Med Sci"},{"key":"2024062101002341000_2024.06.15.24308845v1.43","doi-asserted-by":"crossref","unstructured":"Schreyer L , Mittermeier C , Franz MJ , et al. Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and Senescence. Cancers (Basel) 2021;13.","DOI":"10.3390\/cancers13215373"},{"key":"2024062101002341000_2024.06.15.24308845v1.44","doi-asserted-by":"crossref","unstructured":"Litwiniuk A , Baranowska-Bik A , Doma\u0144ska A , Kalisz M , Bik W . Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases. Pharmaceuticals (Basel) 2021;14.","DOI":"10.3390\/ph14121221"},{"key":"2024062101002341000_2024.06.15.24308845v1.45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","article-title":"Mitochondrial control of inflammation","volume":"23","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2024062101002341000_2024.06.15.24308845v1.46","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-010-1545-0"},{"key":"2024062101002341000_2024.06.15.24308845v1.47","doi-asserted-by":"crossref","unstructured":"P\u00e9ladeau C , Sandhu JK . Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases. Int J Mol Sci 2021;22.","DOI":"10.3390\/ijms22116068"},{"key":"2024062101002341000_2024.06.15.24308845v1.48","doi-asserted-by":"crossref","unstructured":"Bult\u00e9 D , Rigamonti C , Romano A , Mortellaro A . Inflammasomes: Mechanisms of Action and Involvement in Human Diseases. Cells 2023;12.","DOI":"10.3390\/cells12131766"},{"key":"2024062101002341000_2024.06.15.24308845v1.49","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/keaa473","article-title":"PKM2-dependent glycolysis promotes skeletal muscle cell pyroptosis by activating the NLRP3 inflammasome in dermatomyositis\/polymyositis","volume":"60","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"2024062101002341000_2024.06.15.24308845v1.50","doi-asserted-by":"crossref","unstructured":"Kummer K , Bertram I , Zechel S , Hoffmann DB , Schmidt J. Inflammasome in Skeletal Muscle: NLRP3 Is an Inflammatory Cell Stress Component in Inclusion Body Myositis. Int J Mol Sci 2023;24.","DOI":"10.3390\/ijms241310675"},{"key":"2024062101002341000_2024.06.15.24308845v1.51","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4235"},{"key":"2024062101002341000_2024.06.15.24308845v1.52","first-page":"8408574","article-title":"TRIM72 Alleviates Muscle Inflammation in mdx Mice via Promoting Mitophagy-Mediated NLRP3 Inflammasome Inactivation","volume":"2023","year":"2023","journal-title":"Oxidative medicine and cellular longevity"},{"key":"2024062101002341000_2024.06.15.24308845v1.53","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1980"},{"key":"2024062101002341000_2024.06.15.24308845v1.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62994-X"},{"key":"2024062101002341000_2024.06.15.24308845v1.55","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100050"},{"key":"2024062101002341000_2024.06.15.24308845v1.56","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/nan.12038","article-title":"Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres","volume":"39","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2024062101002341000_2024.06.15.24308845v1.57","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-009-0564-6"},{"key":"2024062101002341000_2024.06.15.24308845v1.58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrrheum.2018.48","article-title":"Risk factors and disease mechanisms in myositis","volume":"14","year":"2018","journal-title":"Nature reviews Rheumatology"},{"key":"2024062101002341000_2024.06.15.24308845v1.59","first-page":"103","article-title":"Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis","volume":"30","year":"2011","journal-title":"Acta Myol"},{"key":"2024062101002341000_2024.06.15.24308845v1.60","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad4583"},{"key":"2024062101002341000_2024.06.15.24308845v1.61","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0072-x"},{"key":"2024062101002341000_2024.06.15.24308845v1.62","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrd.2018.174","article-title":"Mitochondria as a therapeutic target for common pathologies","volume":"17","year":"2018","journal-title":"Nature reviews Drug discovery"},{"key":"2024062101002341000_2024.06.15.24308845v1.63","doi-asserted-by":"crossref","unstructured":"Zheng C , Nguyen KK , Vishnivetskiy SA , Gurevich VV , Gurevich EV . Arrestin-3 binds parkin and enhances parkin-dependent mitophagy. J Neurochem 2024.","DOI":"10.1111\/jnc.16043"},{"key":"2024062101002341000_2024.06.15.24308845v1.64","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00822-2"},{"key":"2024062101002341000_2024.06.15.24308845v1.65","doi-asserted-by":"crossref","first-page":"175300","DOI":"10.1016\/j.ejphar.2022.175300","article-title":"NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson\u2019s disease","volume":"934","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"2024062101002341000_2024.06.15.24308845v1.66","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150827095102"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.06.15.24308845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:03:25Z","timestamp":1768507405000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.06.15.24308845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,16]]},"references-count":66,"URL":"https:\/\/doi.org\/10.1101\/2024.06.15.24308845","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1002\/jcsm.13672","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,6,16]]},"subtype":"preprint"}}